A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday.Officials with the Michigan health system said the study found the drug “significantly” decreased the death rate of patients involved in the analysis.The study analyzed 2,541 patients hospitalized among the system’s six hospitals…
3 min read This story is part of a series on 10 life-saving medical breakthroughs. Click here to read the rest. ANTONIO TORRES, A 24-year-old from Denver, used to spend six hours each day bathing and meticulously wrapping the red, raw skin along his shoulders and spine. “My wounds take up a large percentage of
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing COVID-19 in people aged 12 years or older. The vaccine was approved in May 2025 by the US FDA for individuals aged 65 years or older or aged 12-64 years
KFF Health News chief Washington correspondent Julie Rovner discussed Affordable Care Act subsidies on Crooked Media’s What a Day on Dec. 10 and on Slate’s What Next on Dec. 9. Click here to hear Rovner on What a Day. Click here to hear Rovner on What Next. KFF Health News Washington health policy reporter Amanda